Catecholamines in depression: A cumulative study of urinary norepinephrine and its major metabolites in unipolar and bipolar depressed patients versus healthy volunteers at the NIMH

Psychiatry Research

Volumn 87, Issue 1, 1999, Pages 21-27

  Grossman, Fred ^a   Potter, William Z ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

3 methoxy 4 hydroxyphenylglycol; Norepinephrine; Normetanephrine; Vanillylmandelic acid

Indexed keywords

4 HYDROXY 3 METHOXYPHENYLETHYLENE GLYCOL; CATECHOLAMINE; CATECHOLAMINE DERIVATIVE; NORADRENALIN; NORMETADRENALIN; VANILMANDELIC ACID;

ADULT; ARTICLE; BIPOLAR DEPRESSION; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; FEMALE; HUMAN; MALE; METABOLITE; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0032852971     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-1781(99)00055-4     Document Type: Article

References (28)

1. Ågren H. Depressive symptom patterns and urinary MHPG excretion. Psychiatry Research. 6:1982;185-196.
2. Bunney W.E. Jr., Hamburg D.A. Methods for reliable longitudinal observation of behavior. Archives of General Psychiatry. 9:1963;114-128.
3. Charney D., Heninger G., Sternberg D., Landis H. Abrupt discontinuation of tricyclic antidepressant drugs: evidence for noradrenergic hyperactivity. British Journal of Psychiatry. 141:1982;377-386.
4. Davis J.M., Koslow S.H., Gibbons R.D., Maas J.W., Bowden C.L., Casper R., Hanin I., Javaid J.I., Chang S.S., Stokes P.E. Cerebrospinal fluid and urinary biogenic amines in depressed patients and healthy controls. Archives of General Psychiatry. 45:1988;705-717.
5. deVilliers A.S., Russell V.A., Carstens M.E., Aalbers C., Gagiano C.A., Chalton D.O., Taljaard J.J. Noradrenergic function and hypothalamic-pituitary-adrenal axis activity in primary unipolar major depressive disorder. Psychiatry Research. 22:1987;127-140.
6. Esler M., Turbott J., Schwarz R. The peripheral kinetics of norepinephrine in depressive illness. Archives of General Psychiatry. 39:1982;295-300.
7. Goodwin F.K., Jamison K.R. Biochemical and pharmacologic studies. Goodwin F.K., Jamison K.R. Manic Depressive Illness. 1990;416-495 Oxford University Press, New York.
8. Gordon E., Olover J., Black K., Kopin I.J. Simultaneous assay by mass fragmentography of vanillylmandelic acid, homovanillic acid, and 3-methoxy-4-hydroxyphenylethyleneglycol in cerebral fluid and urine. Biochemical Medicine. 11:1974;32-40.
9. Karoum F., Neff N. Quantitative gas chromatography-mass spectrometry (GC-MS) of biogenic amines: theory and practice. Spector S., Beck N. Modern Methods in Pharmacology. 1982;39-54 Alan Liss, Inc. New York.
10. Kopin I.J. Catecholamine metabolism: basic aspects and clinical significance. Pharmacology Review. 37:1985;333-364.
11. Koslow S.H., Maas J.W., Bowden C.L., Davis J.M., Hanin I., Javaid J. CSF and urinary biogenic amines and metabolites in depression and mania. A controlled, univariate analysis. Archives of General Psychiatry. 40:1983;999-1010.
12. Linnoila M., Karoum F., Calil H.M., Kopin I.J., Potter W.Z. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients. Archives of General Psychiatry. 39:1982;1025-1028.
13. Linnoila M., Guthrie S., Lane E.A., Karoum F., Rudorfer M., Potter W.Z. Clinical studies on norepinephrine metabolism: how to interpret the numbers. Psychiatry Research. 17:1986;229-239.
14. Maas J.W., Koslow S.H., Davis J., Katz M., Frazer A., Bowden C.L., Berman N., Gibbons R., Stokes P., Landis H. Catecholamine metabolism and disposition in healthy and depressed subjects. Archives of General Psychiatry. 44:1987;337-344.
15. Muscettola G., Potter W.Z., Pickar D., Goodwin F.K. Urinary 3-methoxy-4-hydroxyphenylglycol and major affective disorders. Archives of General Psychiatry. 41:1984;337-342.
16. Potter W.Z., Linnoila M. Biochemical classifications of diagnostic subgroups and D-type scores. Archives of General Psychiatry. 46:1989;269-271.
17. Potter W.Z., Calil H.M., Extein I., Gold P.W., Wehr T.A., Goodwin F.K. Specific norepinephrine and serotonin uptake inhibitors in man: a cross-over study with pharmacokinetic, biochemical, neuroendocrine and behavioral patterns. Acta Psychiatrica Scandinavica. Suppl. 290:1981;152-165.
18. Potter, W.Z., Muscettola, G., Godwin, F.K., 1983. Sources of variance in clinical studies of MHPG. In: Maas, J.W. (Eds.), MHPG: Basic Mechanisms and Psychopathology. Academic Press, New York.
19. Roth K.A., Mefford I.M., Barchas J.O. Epinephrine, norepinephrine, dopamine, and serotonin: differential effects of acute and chronic stress on regional brain amines. Brain Research. 239:1982;417-424.
20. Roy A., Pickar D., Linnoila M., Potter W.Z. Plasma norepinephrine level in affective disorders: relationship to melancholia. Archives of General Psychiatry. 42:1985;1181-1185.
21. Roy A., Guthrie S., Pickar D., Linnoila M. Plasma norepinephrine responses to cold challenge in depressed patients and normal controls. Psychiatry Research. 21:1987;161-167.
22. Roy A., Pickar D., De Jong J., Karoum F., Linnoial M. Norepinephrine and its metabolites in cerebrospinal fluid, plasma, and urine. Relationship to hypothalamic-pituitary-adrenal axis function in depression. Archives of General Psychiatry. 45:1988;849-857.
23. Rudorfer M.V., Ross R.J., Linnoila M., Sherer M.A., Potter W.Z. Exaggerated orthostatic responsivity of plasma norepinephrine in depression. Archives of General Psychiatry. 42:1985;1186-1192.
24. Scheinin M., Illi A., Koulu M., Ojala-Karlsson O. Norepinephrine metabolites in plasma as indicators of pharmacological inhibition of monoamine oxidase and catechol O-methyltransferase. Advances in Pharmacology. 42:1998;367-370.
25. Schildkraut J.J., Orsulak P.J., Schatzberg A.F., Cole J.O., Rosenbaum A.H. Biochemical discrimination of subgroups of depressive disorders based on differences in catecholamine metabolism. Usdin E., Hanin I. Biological Markers in Psychiatry and Neurology. 1978;23-33 Pergomen Press, New York.
26. Spitzer R.L., Endicott J., Robins E. Research Diagnostic Criteria: rationale and reliability. Archives of General Psychiatry. 35:1978;773-782.
27. Veith, R.C., Halter, J.B., Murburg, M.M., Barnes, R.F., Villacre, E., Bachus, F.I., 1985. Increased plasma NE appearance rate in dexamethasone resistant depression. Fourth World Congress of Biological Psychiatry, pp. 186.
28. Veith R.C., Barnes R.F., Villacres R.C., Murburg M.M., Raskind M.A., Borson S. Plasma catecholamines and norepinephrine kinetics in depression and panic disorder. Belmaker R. Catecholamines: Clinical Aspects. 1988;197-202 Alan Liss, Inc. New York.